US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biologics Market Research Reports & Industry Analysis

A biologic medical product or a biologic or biological, is a medicinal product such as a vaccine, blood or blood component, gene therapy, tissue, recombinant therapeutic protein, or living cells that are used as therapeutics to treat diseases. Biologics are created by biologic processes, rather than being chemically synthesized. Biologics can be composed of sugars, proteins, or nucleic acids or a complex combination of these substances.
They may be living entities such as cells and tissues. Biologics are isolated from a variety of natural sources that can be human, animal, or microorganism.
RSS Feeds

Biologics Industry Research & Market Reports

< prev 1    3  4  
U.S. Market for Soft Tissue Reinforcement and Regeneration 2015
10/1/2014 | published by: iData Research, Inc.
... defined as aggregations of similarly specialized cells which collectively function to connect, support or surround other structures and organs of the body. These tissues include tendons, ligaments, fascia, skin, fibrous tissues, fat, synovial membranes, muscles, ...  |  read more...
USD 6,995
Biopharmaceutical and Vaccine Production Markets
8/29/2014 | published by: Kalorama Information
... stages of clinical drug testing for new biopharmaceuticals, as manufacturers decide when and how to risk production capital to upscale while anticipating FDA or EMA approval. During the past five years, estimates for biopharmaceuticals have ...  |  read more...
USD 3,995
Freeze Drying / Lyophilization Equipment Market by Scale (Lab, Pilot, & Industrial), Technology (Rotary, Manifold, & Tray - style) & by Accessories (Loading/Unloading System, Vacuum System, Clean-in-Place System, Control System) - Global Forecast to 2019
9/9/2014 | published by: MarketsandMarkets
... 2019 The freeze drying equipment market provided in this report covers both, freeze drying systems or freeze dryers and freeze drying accessories. The equipment market is further segmented on the basis of scale of operations ...  |  read more...
USD 4,650
Lyophilization Market by Equipment Type (Benchtop, Mobile, Industrial, & Laboratory), Industry (Food, Pharmaceutical, Biotechnology, Surgical Procedure, & Others), Technology (Tray-style, Manifold, & Rotary) & Geography - Global Trends & Forecast to 2019
9/19/2014 | published by: MarketsandMarkets
... freeze-drying has significant applications in the food, pharmaceutical, and biotechnology industry and is used as a standard process to stabilize, store, and increase the shelf-life of products. In the food industry, freeze-drying is used for ...  |  read more...
USD 4,650
PAREXEL Biopharmaceutical Statistical Sourcebook 2014/2015
7/1/2014 | published by: Barnett Educational Services
... illustrations, and analyses, the Sourcebook provides the latest intelligence on every aspect of biopharmaceutical development – from product discovery, to R&D performance and productivity, to time-to-market trends. With real-world analysis and key contributions from leading ...  |  read more...
USD 425
Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market
7/14/2014 | published by: GBI Research
... “Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market”, which provides in-depth analysis of the critical care market in the US, UK, France, ...  |  read more...
USD 4,995
ROG – Penzberg Biologic Manufacturing Facility – Bavaria - Construction Project Profile
5/22/2014 | published by: World Market Intelligence
... including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts. World "ROG – Penzberg Biologic Manufacturing ...  |  read more...
USD 75
Biologicals in Oncology: Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 137 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 547 drug targets that are included ...  |  read more...
USD 11,025
Biologicals in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... developing 1686 biological drugs in 3815 developmental projects in cancer. In addition, there are 28 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 932 drugs. Biologicals In ...  |  read more...
USD 11,246
Biosimilars and Follow-On Biologics - World Industry and Market Prospects 2014-2024
5/1/2014 | published by: Visiongain
... you revenue predictions for those biological drugs from 2014, helping you stay ahead. For those therapies you find financial data, R&D trends, opportunities and selling prospects. In that new analysis you get sales forecasts to ...  |  read more...
USD 3,004
Biopharmaceuticals Markets in China
6/1/2014 | published by: Asia Market Information & Development Company
... examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are ...  |  read more...
USD 4,000
Can new biologic therapies expand the severe asthma market? - Physician Views:
6/3/2014 | published by: FirstWord
... the regulatory and commercial arenas over the next few years. Analysts are suitably expectant, as are developers, with there being some suggestion that the patient population eligible for treatment with these compounds will expand significantly ...  |  read more...
USD 645
Multiple Sclerosis (MS) Drugs and Biologics: Technologies and Global Markets
6/1/2014 | published by: BCC Research
... to grow to nearly $14.2 billion in 2018 with a compound annual growth rate (CAGR) of 5.4% over the five-year period from 2013 to 2018. This report provides: An overview of the global market for ...  |  read more...
USD 6,650
The 11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
4/1/2014 | published by: BioPlan Associates, Inc.
... pages of data-rich analysis will help improve your decision-making in biomanufacturing operations, with in-depth analysis of capacity, production trends, benchmarks, and much more: Biosimilars pipeline in development In-depth analysis of key data, capacity, production trends, ...  |  read more...
USD 895
Lyophilisation for Pharmaceuticals: Products and Services 2014-2024
2/11/2014 | published by: Visiongain
... revenues to 2024, assessing data, trends, opportunities and prospects there. Our new study lets you assess projected sales at world market, submarket and national level to 2024. You will see financial results, interviews, trends, opportunities, ...  |  read more...
USD 3,004
Biologics - Next-Generation Biologics: R&D, Industry and Market 2014-2024
4/2/2014 | published by: Visiongain
... attract potential billion-dollar deals with pharmaceutical partners, with up-front fees in excess of $100m. This demonstrates a confidence in the technology from the pharmaceutical industry. In the second half of the period 2014-2024, submarket growth ...  |  read more...
USD 3,004
PSORIASIS – PLAQUE PSORIASIS & PSORIATIC ARTHRITIS : NOVEL ORAL DRUGS AND BIOLOGICS TO CHANGE FUTURE TREATMENT PARADIGM
2/24/2014 | published by: MP Advisors
... considerably and improved patients’ pain, function, and quality of life. Approved biologics fill in a critical unmet need of limited efficacy of DMARDs; however, as in most cases one drug does not fit the bill ...  |  read more...
USD 2,500
PharmaPoint: Ulcerative Colitis - US Drug Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the ...  |  read more...
USD 4,995
Frontier Pharma: Systemic Lupus Erythematosus - Identifying and Commercializing First-in-Class Innovation
12/31/2013 | published by: GBI Research
... biologic, Benlysta (belimumab), generated sales of $111m in 2012, there is little evidence that the drug’s performance is significantly superior to other B-cell targeted therapies such as Rituxan (rituximab), which is often used off-license to ...  |  read more...
USD 3,500
Vaccines, Skin Replacement Products and Biologicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325414
2/11/2014 | published by: Plunkett Research, Ltd.
... save countless hours of research. Core Benefits to Customer: 1) Comprehensive overview of an industry’s financial results, ratios, vital statistics and metrics in one package 2) Complete benchmarking of the industry and its top companies ...  |  read more...
USD 1,995
Humira (Crohn’s Disease) - Forecast and Market Analysis to 2022
1/31/2014 | published by: GlobalData
... in an attempt to dislodge the stronghold of the TNF inhibitors, as they aim to tap into the lucrative portion of the CD therapeutics market. If their promising safety and efficacy profiles translate to clinical ...  |  read more...
USD 3,495
Bolus Injectors Market, 2014-2024
11/1/2013 | published by: Roots Analysis
... auto-injectors, the market has come a long way. Taking the concept of self-injectors to a new stratum, ‘Bolus Injectors’ have surfaced recently. Also known as non-insulin patch pumps, these devices not only offer a range ...  |  read more...
USD 1,699
Biotech API Manufacturing Services: World Industry and Market 2014-2024
12/12/2013 | published by: Visiongain
... you predictions of those revenues from 2014. There you see financial data, also assessing trends, technologies, clients' needs, and opportunities. That study gives you sales forecasts to 2024 at overall world market, submarket, and national ...  |  read more...
USD 3,004
Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need
1/31/2014 | published by: GBI Research
... Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need , which provides insights into three therapeutic indications in gastrointestinal disorders in Asia-Pacific (APAC) markets of ...  |  read more...
USD 4,995
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth
2/7/2014 | published by: GBI Research
... Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth”. The systemic psoriasis market is forecast to grow substantially over the forecast period from $5.0 billion in 2013 to ...  |  read more...
USD 4,995
< prev 1    3  4